Insider Trades of KERINS PATRICK J Information

Click on the column header to resort ascending (▲) or descending (▼).

Individual Insider Trades

Company ▼ Relation Last Date Type Tran OwnerType Shares Traded Last Price Shares Held
TRACON PHARMACEUTICALS, INC. Beneficial Owner (10%) 02/04/2015 Form 4 Acquisition (Non Open Market) indirect 1,388,474 0 1,388,474
TRACON PHARMACEUTICALS, INC. Beneficial Owner (10%) 02/04/2015 Form 4 Buy indirect 500,000 10 1,888,474
TESARO, INC. Beneficial Owner (10%) 06/01/2015 Form 4 Acquisition (Non Open Market) indirect 10,000 0 10,000
TESARO, INC. Beneficial Owner (10%) 06/01/2015 Form 4 Disposition (Non Open Market) indirect 1,010,000 0 8,854,255
TESARO, INC. Beneficial Owner (10%) 06/01/2015 Form 4 Acquisition (Non Open Market) direct 504 0 1,333
TESARO, INC. Beneficial Owner (10%) 03/18/2016 Form 4 Buy indirect 710,429 35.19 9,564,684
SUNESIS PHARMACEUTICALS INC Beneficial Owner (10%) 08/08/2014 Form 4 Sell indirect 675,000 6.6201 4,961,573
SUNESIS PHARMACEUTICALS INC Beneficial Owner (10%) 08/12/2014 Form 4 Sell indirect 35,540 6.7583 4,926,033
SUNESIS PHARMACEUTICALS INC Beneficial Owner (10%) 08/27/2014 Form 4 Sell indirect 108,300 8.17 4,817,733
SUNESIS PHARMACEUTICALS INC Beneficial Owner (10%) 08/28/2014 Form 4 Sell indirect 146,800 7.8668 4,670,933
SUNESIS PHARMACEUTICALS INC Beneficial Owner (10%) 08/29/2014 Form 4 Sell indirect 11,600 7.506 4,659,333
ROKA BIOSCIENCE, INC. Beneficial Owner (10%) 07/22/2014 Form 4 Acquisition (Non Open Market) indirect 2,828,743 0 2,833,477
ROKA BIOSCIENCE, INC. Beneficial Owner (10%) 07/22/2014 Form 4 Buy indirect 383,333 12 3,216,810
MIRNA THERAPEUTICS, INC. Beneficial Owner (10%) 10/05/2015 Form 4 Acquisition (Non Open Market) indirect 1,825,209 0 2,082,725
MIRNA THERAPEUTICS, INC. Beneficial Owner (10%) 10/06/2015 Form 4 Acquisition (Non Open Market) indirect 289,166 0 2,114,375
MIRNA THERAPEUTICS, INC. Beneficial Owner (10%) 10/06/2015 Form 4 Buy indirect 857,142 7 2,971,517
LOXO ONCOLOGY, INC. Beneficial Owner (10%) 08/06/2014 Form 4 Acquisition (Non Open Market) indirect 1,558,651 0 1,558,651
LOXO ONCOLOGY, INC. Beneficial Owner (10%) 08/06/2014 Form 4 Buy indirect 230,769 13 1,789,420
INTERLEUKIN GENETICS INC Beneficial Owner (10%) 12/23/2014 Form 4 Buy indirect 19,868,965 0.1003 35,298,087
EPIZYME, INC. Beneficial Owner (10%) 08/14/2014 Form 4 Acquisition (Non Open Market) indirect 12,900 0 12,900